This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
28 Apr 2022
MAHSC Seminar Series: ‘Novel diagnostic & therapeutic approaches’
Manchester Academic Health Science Centre (MAHSC) is a partnership between The University of Manchester, Manchester University NHS Foundation Trust, The Christie NHS Foundation Trust, Salford Royal NHS Foundation Trust (part of the Northern Care Alliance), and Greater Manchester Mental Health NHS Foundation Trust to unite leading healthcare providers with world-class academics and researchers.
In April 2020, Manchester Academic Health Science Centre (MAHSC), part of Health Innovation Manchester, was officially designated by National Institute for Health Research (NIHR), NHS England and NHS Improvement up to 2025. The MAHSC Seminar Series showcases the great discovery and clinical science being undertaken within Manchester and its impact on the health of the local population.
The series gives a local platform to the nationally and internationally renowned scientists of MAHSC to share their work with clinical, non-clinical, university colleagues, but also crucially members of the wider community seeking insight into innovations in the delivery of healthcare.
This months seminar was centered on ‘Advanced Materials in Medicine: Research opportunities to aid development of novel diagnostic and therapeutic approaches’ and was lead by Advanced Materials in Medicine at Manchester.
Speakers included:
- Professor Julie Gough, Professor of Biomaterials and Tissue Engineering, FIMMM, Department of Materials & Henry Royce Institute
- Dr Stephen M. Richardson, Senior Lecturer in Cell and Tissue Engineering, Co-director of Advanced Materials in Medicine
Professor Gough gave an overview of the current ongoing projects across AMM Academics such as the Manchester Biogel peptide hydrogels and tendon repair.
Dr. Richardson spoke of recent workshops that have looked at co-cultures and organoids with applications in Cancer. He discussed how to get these cell interactions which can then be used to better understand not only that particular disease, but also other diseases and areas of basic science such as stem cells by using the high level technologies available in Manchester.
Watch session here:
MAHSC Seminar Series: ‘Novel diagnostic & therapeutic approaches’